These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

233 related items for PubMed ID: 22859861

  • 1. Angiopoietin-2 enhances survival in experimental sepsis induced by multidrug-resistant Pseudomonas aeruginosa.
    Tzepi IM, Giamarellos-Bourboulis EJ, Carrer DP, Tsaganos T, Claus RA, Vaki I, Pelekanou A, Kotsaki A, Tziortzioti V, Topouzis S, Bauer M, Papapetropoulos A.
    J Pharmacol Exp Ther; 2012 Nov; 343(2):278-87. PubMed ID: 22859861
    [Abstract] [Full Text] [Related]

  • 2. n-6 polyunsaturated fatty acids enhance the activities of ceftazidime and amikacin in experimental sepsis caused by multidrug-resistant Pseudomonas aeruginosa.
    Giamarellos-Bourboulis EJ, Mouktaroudi M, Adamis T, Koussoulas V, Baziaka F, Perrea D, Karayannacos PE, Giamarellou H.
    Antimicrob Agents Chemother; 2004 Dec; 48(12):4713-7. PubMed ID: 15561848
    [Abstract] [Full Text] [Related]

  • 3. Shrimp (Penaeus monodon) anti-lipopolysaccharide factor reduces the lethality of Pseudomonas aeruginosa sepsis in mice.
    Pan CY, Chao TT, Chen JC, Chen JY, Liu WC, Lin CH, Kuo CM.
    Int Immunopharmacol; 2007 May; 7(5):687-700. PubMed ID: 17386416
    [Abstract] [Full Text] [Related]

  • 4. Paradoxical synergistic effects of tumour necrosis factor and interleukin 1 in murine gut-derived sepsis with Pseudomonas aeruginosa.
    Matsumoto T, Tateda K, Miyazaki S, Furuya N, Ohno A, Ishii Y, Hirakata Y, Yamaguchi K.
    Cytokine; 1999 May; 11(5):366-72. PubMed ID: 10328876
    [Abstract] [Full Text] [Related]

  • 5. Impact of multidrug resistance on experimental empyema by Pseudomonas aeruginosa.
    Giamarellos-Bourboulis EJ, Tzepi I, Tsovolou I, Spyridaki A, Tsaganos T, Vaki I, Kotsaki A, Polychronopoulos V.
    Respiration; 2011 May; 82(1):46-53. PubMed ID: 21525725
    [Abstract] [Full Text] [Related]

  • 6. Continuous administration of PBP-2- and PBP-3-specific beta-lactams causes higher cytokine responses in murine Pseudomonas aeruginosa and Escherichia coli sepsis.
    Buijs J, Dofferhoff AS, Mouton JW, van der Meer JW.
    J Antimicrob Chemother; 2007 May; 59(5):926-33. PubMed ID: 17395686
    [Abstract] [Full Text] [Related]

  • 7. Oleuropein: a novel immunomodulator conferring prolonged survival in experimental sepsis by Pseudomonas aeruginosa.
    Giamarellos-Bourboulis EJ, Geladopoulos T, Chrisofos M, Koutoukas P, Vassiliadis J, Alexandrou I, Tsaganos T, Sabracos L, Karagianni V, Pelekanou E, Tzepi I, Kranidioti H, Koussoulas V, Giamarellou H.
    Shock; 2006 Oct; 26(4):410-6. PubMed ID: 16980890
    [Abstract] [Full Text] [Related]

  • 8. Pre-treatment with probiotics prolongs survival after experimental infection by multidrug-resistant Pseudomonas aeruginosa in rodents: an effect on sepsis-induced immunosuppression.
    Machairas N, Pistiki A, Droggiti DI, Georgitsi M, Pelekanos N, Damoraki G, Kouraklis G, Giamarellos-Bourboulis EJ.
    Int J Antimicrob Agents; 2015 Apr; 45(4):376-84. PubMed ID: 25601531
    [Abstract] [Full Text] [Related]

  • 9. The significance of oxidant/antioxidant balance for the pathogenesis of experimental sepsis by multidrug-resistant Pseudomonas aeruginosa.
    Koussoulas V, Giamarellos-Bourboulis EJ, Adamis T, Mouktaroudi M, Sabracos L, Perrea D, Giamarellou H, Dionyssiou-Asteriou A.
    Prostaglandins Leukot Essent Fatty Acids; 2005 Jan; 72(1):41-7. PubMed ID: 15589398
    [Abstract] [Full Text] [Related]

  • 10. Experimental sepsis using Pseudomonas aeruginosa: the significance of multi-drug resistance.
    Giamarellos-Bourboulis EJ, Koussoulas V, Panagou C, Adamis T, Baziaka F, Skiadas I, Perrea D, Dionyssiou-Asteriou A, Giamarellou H.
    Int J Antimicrob Agents; 2004 Oct; 24(4):357-61. PubMed ID: 15380261
    [Abstract] [Full Text] [Related]

  • 11. Improved bacterial clearance and decreased mortality can be induced by LPS tolerance and is not dependent upon IFN-gamma.
    Murphey ED, Fang G, Varma TK, Sherwood ER.
    Shock; 2007 Mar; 27(3):289-95. PubMed ID: 17304110
    [Abstract] [Full Text] [Related]

  • 12. Early cutaneous alterations in experimental sepsis by Pseudomonas aeruginosa.
    Petropoulou H, Giamarellos-Bourboulis EJ, Kavatzas N, Stratigos A, Mouktaroudi M, Adamis T, Baziaka F, Katsambas AD, Stavrianeas NG.
    Dermatology; 2004 Mar; 209(2):111-6. PubMed ID: 15316164
    [Abstract] [Full Text] [Related]

  • 13. Improved survival in experimental sepsis with an orally administered inhibitor of apoptosis.
    Weaver JG, Rouse MS, Steckelberg JM, Badley AD.
    FASEB J; 2004 Aug; 18(11):1185-91. PubMed ID: 15284218
    [Abstract] [Full Text] [Related]

  • 14. Interleukin 4 Deficiency Reverses Development of Secondary Pseudomonas aeruginosa Pneumonia During Sepsis-Associated Immunosuppression.
    Song Z, Zhang J, Zhang X, Li D, Wang H, Xu X, Xu W, Yin Y, Cao J.
    J Infect Dis; 2015 May 15; 211(10):1616-27. PubMed ID: 25489003
    [Abstract] [Full Text] [Related]

  • 15. Early apoptosis of blood monocytes is a determinant of survival in experimental sepsis by multi-drug-resistant Pseudomonas aeruginosa.
    Antonopoulou A, Raftogiannis M, Giamarellos-Bourboulis EJ, Koutoukas P, Sabracos L, Mouktaroudi M, Adamis T, Tzepi I, Giamarellou H, Douzinas EE.
    Clin Exp Immunol; 2007 Jul 15; 149(1):103-8. PubMed ID: 17488299
    [Abstract] [Full Text] [Related]

  • 16. Phosphodiesterase inhibition decreases nuclear factor-kappaB activation and shifts the cytokine response toward anti-inflammatory activity in acute endotoxemia.
    Coimbra R, Melbostad H, Loomis W, Tobar M, Hoyt DB.
    J Trauma; 2005 Sep 15; 59(3):575-82. PubMed ID: 16361898
    [Abstract] [Full Text] [Related]

  • 17. A multidrug-resistant Pseudomonas aeruginosa isolate from a lethal case of sepsis induces necrosis of human neutrophils.
    Mencacci A, Cenci E, Repetto A, Mazzolla R, Bistoni F, Aversa F, Aloisi T, Vecchiarelli A.
    J Infect; 2006 Dec 15; 53(6):e259-64. PubMed ID: 16650478
    [Abstract] [Full Text] [Related]

  • 18. Potential therapeutic role of histatin derivative P-113d in experimental rat models of Pseudomonas aeruginosa sepsis.
    Cirioni O, Giacometti A, Ghiselli R, Orlando F, Kamysz W, D'Amato G, Mocchegiani F, Lukasiak J, Silvestri C, Saba V, Scalise G.
    J Infect Dis; 2004 Jul 15; 190(2):356-64. PubMed ID: 15216473
    [Abstract] [Full Text] [Related]

  • 19. Cytokine production after intravenous or peritoneal gram-negative bacterial challenge in mice. Comparative protective efficacy of antibodies to tumor necrosis factor-alpha and to lipopolysaccharide.
    Zanetti G, Heumann D, Gérain J, Kohler J, Abbet P, Barras C, Lucas R, Glauser MP, Baumgartner JD.
    J Immunol; 1992 Mar 15; 148(6):1890-7. PubMed ID: 1541827
    [Abstract] [Full Text] [Related]

  • 20. Reverse kinetics of angiopoietin-2 and endotoxins in acute pyelonephritis: Implications for anti-inflammatory treatment?
    Safioleas K, Giamarellos-Bourboulis EJ, Carrer DP, Pistiki A, Sabracos L, Deliveliotis C, Chrisofos M.
    Cytokine; 2016 May 15; 81():28-34. PubMed ID: 26844659
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.